Skip to contentOrbiMed Capital GP VII LLC — Passage BIO, Inc. insider: 98 transactions · InsiderLensOrbiMed Capital GP VII LLC
- Director at MBX Biosciences, Inc. · on record since Sep 17, 2024
- 10% owner at MBX Biosciences, Inc. · on record since Sep 17, 2024
- Director at Venetian-1 Acquisition Corp. · on record since Nov 5, 2024
- Director at Q32 Bio Inc. · on record since Jun 1, 2026
- 10% owner at Q32 Bio Inc. · on record since Jun 1, 2026
- 10% owner at THORATEC CORP · on record since Dec 13, 2018
- Director at ProNAi Therapeutics Inc · on record since Nov 26, 2019
- 10% owner at ProNAi Therapeutics Inc · on record since Nov 26, 2019
- Director at Arcutis Biotherapeutics, Inc. · on record since Jan 30, 2020
- 10% owner at Arcutis Biotherapeutics, Inc. · on record since Jan 30, 2020
- 10% owner at Passage BIO, Inc. · on record since Feb 27, 2020
- Director at 11 GOOD ENERGY INC · on record since Mar 16, 2020
- 10% owner at 11 GOOD ENERGY INC · on record since Mar 16, 2020
- Director at Fusion Pharmaceuticals Inc. · on record since Jun 25, 2020
- Director at Repare Therapeutics Inc. · on record since Jun 25, 2020
- 10% owner at Repare Therapeutics Inc. · on record since Jun 18, 2020
- Director at Keros Therapeutics, Inc. · on record since Apr 13, 2020
- 10% owner at Pandion Therapeutics, Inc. · on record since Jul 16, 2020
- Director at Damora Therapeutics, Inc. · on record since Oct 28, 2020
- 10% owner at Damora Therapeutics, Inc. · on record since Oct 28, 2020
- Director at Kinnate Biopharma Inc. · on record since Dec 9, 2020
- 10% owner at Kinnate Biopharma Inc. · on record since Dec 9, 2020
- Director at Terns Pharmaceuticals, Inc. · on record since Feb 9, 2021
- 10% owner at Terns Pharmaceuticals, Inc. · on record since Feb 9, 2021
- Director at Janux Therapeutics, Inc. · on record since Dec 17, 2021
- 10% owner at THERAVANCE INC · on record since Oct 14, 2021
- Director at THERAVANCE INC · on record since Jan 21, 2022
- Director at TF FINANCIAL CORP · on record since Sep 21, 2022
- 10% owner at TF FINANCIAL CORP · on record since Sep 21, 2022
Insider trading activity of OrbiMed Capital GP VII LLC
- Transactions on record
- 98
- since Dec 13, 2018
- Open-market buys
- 36
- $97.6M
- Open-market sells
- 26
- $31.7M
- Companies traded
- 12
- last filing Apr 17, 2025
Figures computed from official regulatory filings — methodology.
Companies where OrbiMed Capital GP VII LLC has traded
- Passage BIO, Inc.27 tx · $10M · Apr 17, 2025
- Venetian-1 Acquisition Corp.13 tx · $10M · Nov 5, 2024
- 11 GOOD ENERGY INC9 tx · $57.9M · May 20, 2024
- Damora Therapeutics, Inc.6 tx · $742.7K · Aug 2, 2023
- Kinnate Biopharma Inc.9 tx · $3.7M · May 2, 2023
- TF FINANCIAL CORP5 tx · $5.1M · Sep 21, 2022
- Terns Pharmaceuticals, Inc.6 tx · $8.9M · Aug 18, 2022
- Arcutis Biotherapeutics, Inc.4 tx · $19.7M · Jun 28, 2022
- THERAVANCE INC7 tx · $2M · Jan 21, 2022
Track record of OrbiMed Capital GP VII LLC
Statistical track record
Free- Open-market buys
- 39
- Last buy
- May 2, 2023
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of OrbiMed Capital GP VII LLC
Co-insiders of OrbiMed Capital GP VII LLC
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
4 tx · $274.8K · Sep 8, 2021
Shah Rajeev M.11 GOOD ENERGY INC +3
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Apr 17, 2025 | Sell | -10,326 | 0.38 USD | $3.9K | SEC |
| Apr 17, 2025 | Sell | -77,090 | 0.33 USD | $25.4K | SEC |
| Apr 17, 2025 | Sell | -61,638 | 0.33 USD | $20.3K | SEC |
| Jan 8, 2025 | Sell | -75,007 | 0.68 USD | $51K | SEC |
| Jan 8, 2025 | Sell | -52,536 | 0.71 USD | $37.3K | SEC |
| Jan 8, 2025 | Sell | -19,481 | 0.77 USD | $15K | SEC |
| Dec 26, 2024 | Sell | -230,321 | 0.60 USD | $138.2K | SEC |
| Dec 6, 2024 | Sell | -20,903 | 0.82 USD | $17.1K | SEC |
| Dec 6, 2024 | Sell | -76,200 | 0.79 USD | $60.2K | SEC |
| Nov 5, 2024 | Award | 155,120 | 4.00 USD | $620.5K | SEC |
| Nov 5, 2024 | OtherD | -389,078 | 0.00 USD | $0 | SEC |
| Nov 5, 2024 | Award | 808,894 | 4.00 USD | $3.2M | SEC |
| Nov 5, 2024 | Other | 389,078 | 3.60 USD | $1.4M | SEC |
| Nov 5, 2024 | OtherD | -215,146 | 0.00 USD | $0 | SEC |
| Nov 5, 2024 | Other | 215,146 | 3.20 USD | $688.5K | SEC |
| Nov 5, 2024 | Other | 323,916 | 3.20 USD | $1M | SEC |
| Nov 5, 2024 | Other | 230,753 | 3.60 USD | $830.7K | SEC |
| Nov 5, 2024 | OtherD | -74,613 | 0.00 USD | $0 | SEC |
| Nov 5, 2024 | Award | 479,736 | 4.00 USD | $1.9M | SEC |
| Nov 5, 2024 | Other | 74,613 | 3.60 USD | $268.6K | SEC |
| Nov 5, 2024 | OtherD | -230,753 | 0.00 USD | $0 | SEC |
| Nov 5, 2024 | OtherD | -323,916 | 0.00 USD | $0 | SEC |
| Sep 18, 2024 | Sell | -25,631 | 0.73 USD | $18.7K | SEC |
| Sep 18, 2024 | Sell | -111,400 | 0.73 USD | $81.3K | SEC |
| Sep 18, 2024 | Sell | -63,100 | 0.74 USD | $46.7K | SEC |